HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib

Identification of novel anticancer drugs presenting more than one molecular target and efficacy against cancer stem-like cells (CSCs) subpopulations represents a therapeutic need to combat the resistance and the high risk of relapse in patients. In the present work we show how Bozepinib [(RS)-2,6-di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramírez, Alberto, Boulaiz, Houria, Morata-Tarifa, Cynthia, Perán, Macarena, Jiménez, Gema, Picon-Ruiz, Manuel, Agil, Ahmad, Cruz-López, Olga, Conejo-García, Ana, Campos, Joaquín M., Sánchez, Ana, García, María A., Marchal, Juan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116505/
https://www.ncbi.nlm.nih.gov/pubmed/24946763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116505/
https://www.ncbi.nlm.nih.gov/pubmed/24946763

Ejemplares similares